title: [Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment].
abstract: OBJECTIVE
  To evaluate the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment by urologists members of the French Association of Urology (AFU).
  
  
  METHODS
  Internet-based observational survey evaluating indications and practical modalities of IPOP in NMIBC treatment using questionnaire sent in May 2014 to 915 urologists.
  
  
  RESULTS
  Two hundred ninety-eight urologists participated in the survey (response rate: 32.6%) and 57% prescribed the IPOP. The median frequency of IPOP prescription was 3.3%, and was higher in the academic public sector. The CASE recommendations were self-assessed as known or well-known in 67% of cases. The selections criteria for IPOP were adequately identified by 62% of urologists, without differences according to sectors of activity. The IPOP prescription modalities were declared as an obstacle to the completion for 41.9% of urologists, and especially in the private sector. Completion times of IPOP were declared <24h in 91% of cases. We see that 28.5% of urologists prescribed an urinary alkalization. The average frequency of complications of IPOP was 0.91 per urologist.
  
  
  CONCLUSIONS
  The IPOP prescription frequency was higher among urologists practicing in the academic sector. Neither the level of knowledge of the recommendations nor the frequency of complications of IPOP had explained this difference. However, the prescription modalities were more frequently reported as an obstacle to their completion in the private sector.
  
  
  METHODS
  3.
authors.affiliation: Service d'urologie, hôpital Foch, université de Versailles-Saint-Quentin-en-Yvelines, 40, rue Worth, 92150 Suresnes, France. Electronic address: y.neuzillet@hopital-foch.org.
authors.forename: Y
authors.initials: Y
authors.lastname: Neuzillet
authors.affiliation: Service d'urologie, hôpital privé de la Louvière - générale de santé, 59000 Lille, France.
authors.forename: P
authors.initials: P
authors.lastname: Colin
authors.affiliation: Service d'anatomopathologie, groupe hospitalier Pitié-Salpêtrière, université Pierre-et-Marie-Curie, 75013 Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Comperat
authors.affiliation: Clinique de l'Alma, 75007 Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Dubosq
authors.affiliation: Service d'oncologie médicale, CHU de Nîmes, 30000 Nîmes, France.
authors.forename: N
authors.initials: N
authors.lastname: Houede
authors.affiliation: Service d'urologie, CHU de Reims, 51000 Reims, France.
authors.forename: S
authors.initials: S
authors.lastname: Larre
authors.affiliation: Service d'urologie, hôpital Henri-Mondor, université Paris-Est, 94010 Créteil, France.
authors.forename: A
authors.initials: A
authors.lastname: Masson-Lecomte
authors.affiliation: Service d'urologie, hôpital Bicêtre, université Paris-Sud, 94270 Le Kremlin-Bicêtre, France.
authors.forename: G
authors.initials: G
authors.lastname: Pignot
authors.affiliation: Service de radiologie, CHRU de Lille, 59037 Lille, France.
authors.forename: P
authors.initials: P
authors.lastname: Puech
authors.affiliation: Service d'urologie, CHU Rangueil, 31400 Toulouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Roumiguie
authors.affiliation: Service d'urologie, hôpital Cochin, université Paris-Descartes, 75679 Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Xylinas
authors.affiliation: Service d'urologie, groupe hospitalier Pitié-Salpêtrière, université Pierre-et-Marie-Curie, 75013 Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Mejean
authors.affiliation: Service d'urologie, hôpital européen Georges-Pompidou, université Paris-Descartes, 75015 Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Roupret
mesh_terms: D000283:Administration, Intravesical; D003131:Combined Modality Therapy; D005602:France; D019538:Health Care Surveys; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage*; D009361:Neoplasm Invasiveness; D011182:Postoperative Care / Q000379:methods*; D010818:Practice Patterns, Physicians'; D012955:Societies, Medical; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D014572:Urology
chemical_list: D016685:Mitomycin
keywords: Enquête de pratique; Immediate postoperative instillation; Instillation postopératoire précoce; Non-muscle invasive bladder cancer; Practice survey; Secteur d’activité professionnel; Sector of professional activity; Tumeur de vessie n’infiltrant pas le muscle